Katharina Zeschky

Most-cited papers

1. Binding of CD40L to Mac-1’s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis – but does not affect immunity and thrombosis in mice

   D. Wolf, J. Hohmann, Ansgar Wiedemann, K. Bledzka +20 more

   2011Circulation Research117 citations Open access

   Semantic Scholar

   Save

2. The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice

   I. Hilgendorf, S. Eisele, I. Remer, J. Schmitz +14 more

   2011Arteriosclerosis, Thrombosis and Vascular Biology63 citations Open access

   Semantic Scholar

   Save

3. Abstract 12051: Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis In Mice

   F. Willecke, Katharina Zeschky, D. Wolf, C. Munkel +4 more

   201026 citations

   Semantic Scholar

   Save

4. Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice

   F. Willecke, Shilpa Tiwari, Benjamin Rupprecht, D. Wolf +17 more

   2014Thrombosis and Haemostasis24 citations Open access

   Semantic Scholar

   Save

5. Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice

   F. Willecke, Katharina Zeschky, Alexandra Ortiz Rodriguez, C. Colberg +11 more

   2011PLoS ONE1 citations Open access

   Semantic Scholar

   Save

6. Abstract 12079: The Oral Spleen Tyrosin Kinase Inhibitor Fostamatinib Disodium (R788) Attenuates Inflammation and Atherogenesis in Low Density Lipoprotein Receptor-Deficient Mice

   I. Hilgendorf, S. Eisele, J. Schmitz, I. Remer +8 more

   20101 citations

   Semantic Scholar

   Save

7. 366 THE NOVEL SPLEEN TYROSIN KINASE INHIBITOR FOSTAMATINIB DISODIUM ATTENUATES INFLAMMATION AND ATHEROGENESIS IN LOW DENSITY LIPOPROTEIN RECEPTOR DEFICIENT MICE

   I. Hilgendorf, I. Remer, S. Eisele, Katharina Zeschky +5 more

   20110 citations

   Semantic Scholar

   Save

8. 302 CB2 RECEPTOR SIGNALING DOES NOT MODULATE ATHEROGENESIS IN MICE

   F. Willecke, Katharina Zeschky, D. Wolf, M. Moser +3 more

   20110 citations

   Semantic Scholar

   Save

9. Deficient Mice - Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates

   C. Bode, A. Zirlik, K. Zirlik, Alexandra Ortiz-Rodriguez +12 more

   20110 citations

   Semantic Scholar

   Save

10. Abstract 17228: BMPER is a Modulator of Vascular Inflammation and Endothelial Cell Dysfunction

    T. Helbing, René Rothweiler, Elena Ketterer, S. Wintrich +6 more

    20100 citations

    Semantic Scholar

    Save